Discussion network
|
|
Report providing in-depth analyses of current rules, guidelines or laws regarding biotherapies and recommendations of new regulations capable to facilitate the initiation and conduction of European clinical trials
|
|
Barriers to collaboration in cancer research
|
|
Develop best estimates of survival outcomes for commonest tumours in EU
|
|
Estimate potential for increase in survival resulting from every patient receiving optimal therapy
|
|
Quality of life. Strategies for improvement and coordination of quality of life research
|
|
Cancer survivor. Strategies to tackle consequent societal issues for cured patients or persons alive with cancer
|
|
Analysis and synthesis of National Cancer Plans in Europe. Evaluation of each contribution to the EU 2015 cancer target
|
|
Development of a common European Union Cancer Plan. Evaluation of potential contribution to EU 2015 cancer target
|
|
Design and implement a web based database aimed at collecting all relevant information on clinical trials in oncology being conducted in Europe
|
|
Report providing in-depth analyses of the current research projects of public and private institutions in different Member States regarding the development of prophylactic vaccines against cancers, also providing suggestions for future strategies required to improve collaboration/coordination
|
|
Report on measures for assessing the efficacy of cancer vaccines as anticancer agents
|
|
Guidelines for Translational Research in Europe and Guidelines development for accreditation to conduct Translational research
|
|
Reports of meetings and an integrated report of the results of WP8
|
|
Report on Governance, Legal and Financial Structure of an EEIG
|
|
Enhancing the effectiveness of the Public-Private Partnership in Europe
|
|
Opportunities for Public-Private partnership within Art 169 initiatives
|
|
